Principles and experimental considerations for in vitro transporter interaction assays.

Area of Science:

• Pharmacology
• Drug Metabolism and Pharmacokinetics

Background:

• Drug transporters significantly influence the absorption, distribution, metabolism, and excretion (ADME) of endogenous and exogenous compounds.
• Altered transporter function can lead to variable drug efficacy and toxicity by affecting drug and substrate levels.
• Accurate in vitro models are essential for predicting clinical drug-drug interactions (DDIs).

Purpose of the Study:

• To highlight the importance of in vitro test systems in predicting clinical DDIs.
• To identify key variables that impact the outcomes of in vitro drug transporter assays.
• To provide actionable steps for improving the translatability of in vitro assay results.

Main Methods:

• Review of factors influencing in vitro drug transporter assay outcomes.
• Delineation of variables including test compound characteristics, test systems, assay formats, and experimental design.
• Analysis of how these variables affect the prediction of clinical DDIs.

Main Results:

• In vitro drug transporter assay outcomes are influenced by multiple experimental variables.
• Understanding these variables is key to improving the accuracy and translatability of predictions.
• Optimized experimental design can lead to more reliable risk assessments for clinical DDIs.

Conclusions:

• Improving in vitro assay design and execution is critical for accurate DDI prediction.
• Careful consideration of experimental variables enhances the clinical relevance of drug transporter studies.
• This approach can help avoid unnecessary clinical trials by providing better in vitro predictions.